Press release
Plaque Psoriasis Pipeline Insights, FDA Approvals, Clinical Trials Assessment, and Companies 2024
DelveInsight's, "Plaque Psoriasis Pipeline Insight 2024" report provides comprehensive insights about 75+ companies and 75+ pipeline drugs in the Plaque Psoriasis pipeline landscape. It covers the Plaque Psoriasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.Key Takeaways from the Plaque Psoriasis Pipeline Report
• DelveInsight's Plaque Psoriasis pipeline report depicts a robust space with 75+ active players working to develop 75+ pipeline therapies for Plaque Psoriasis treatment.
• The leading companies working in the Plaque Psoriasis Market include Arcutis Biotherapeutics, Affibody, Akeso Biopharma, Dong-A ST Co., Ltd., DelArrivo, Inc., Bristol-Myers Squibb, Bio-Thera Solutions, Janssen Research & Development, LLC, Meiji Pharma USA Inc., Aldeyra Therapeutics Inc., Amgen, Bioeq GmbH, Can-Fite Biopharma, Hangzhou Highlightll Pharmaceutical Co., Ltd, Nimbus Therapeutics, Sun Pharmaceutical Industries, Jiangsu Hengrui Medicine, Biocon, Pfizer, Ono Pharmaceutical, GC Cell Corporation, Suzhou Zelgen Biopharmaceuticals, Aurigene Discovery Technologies Limited, Celltrion, Tianjin Hemay Pharmaceutical Co., Ltd, Innovent Biologics (Suzhou) Co. Ltd., Sinocelltech, Azora Therapeutics, and others.
• Promising Plaque Psoriasis Pipeline Therapies in the various stages of development include Tapinarof, Tapinarof cream 1%, Bimekizumab, Humira (Adalimumab), SB5 (Adalimumab Biosimilar), and others.
• September 2023: Dermavant Sciences Inc. announced a study of phase 3 clinical trials for Tapinarof Cream 1%. This study is an open-label study, consisting of a 12-week primary treatment phase and an optional 40-week long-term extension phase in which all eligible subjects will receive tapinarof cream, 1% once daily. At the end of the 12-week primary treatment phase subjects will have the option to continue for 40 additional weeks of treatment.
• September 2023: Hangzhou Highlightll Pharmaceutical Co., Ltd announced a study of phase 2 clinical trials for TLL018 tablets. This is a Phase 2, multicenter, randomized, double-blinded, parallel dose group, placebo-controlled, dose-ranging study to evaluate the efficacy and safety of 3 doses of TLL018 as therapy in 120 participants with moderate-to-severe PP.
Request a sample and discover the recent advances in Plaque Psoriasis Treatment Drugs @ Plaque Psoriasis Pipeline Report- https://www.delveinsight.com/report-store/plaque-psoriasis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
In the Plaque Psoriasis pipeline report, detailed description of the drug is given which includes mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, Plaque Psoriasis collaborations, licensing, mergers and acquisition, funding, designations and other product related details.
Plaque Psoriasis Overview
Psoriasis is recognized as the most prevalent immune-mediated inflammatory disease, involving skin and joints and associated with abnormalities of other systems. Plaque psoriasis is the commonest clinical type of psoriasis. Even though the condition is not life-threatening, it is difficult to treat and response rates vary widely.
Find out more about Plaque Psoriasis Therapeutics Assessment @ Plaque Psoriasis Preclinical and Discovery Stage Products- https://www.delveinsight.com/sample-request/plaque-psoriasis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Plaque Psoriasis Emerging Drugs Profile
• ARQ-151: Arcutis Biotherapeutics
• ABY-035: Affibody
• AK101: Akeso Biopharma
Plaque Psoriasis Pipeline Therapeutics Assessment
There are approx. 75+ key companies which are developing the Plaque Psoriasis therapies. The Plaque Psoriasis companies which have their Plaque Psoriasis drug candidates in the most advanced stage, i.e. preregistration include, Arcutis Biotherapeutics.
Learn more about the emerging Plaque Psoriasis Pipeline Therapies @ Plaque Psoriasis Clinical Trials Assessment- https://www.delveinsight.com/sample-request/plaque-psoriasis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Scope of the Plaque Psoriasis Pipeline Report
• Coverage- Global
• Plaque Psoriasis Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
• Plaque Psoriasis Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III
• Plaque Psoriasis Companies- Arcutis Biotherapeutics, Affibody, Akeso Biopharma, Dong-A ST Co., Ltd., DelArrivo, Inc., Bristol-Myers Squibb, Bio-Thera Solutions, Janssen Research & Development, LLC, Meiji Pharma USA Inc., Aldeyra Therapeutics Inc., Amgen, Bioeq GmbH, Can-Fite Biopharma, Hangzhou Highlightll Pharmaceutical Co., Ltd, Nimbus Therapeutics, Sun Pharmaceutical Industries, Jiangsu Hengrui Medicine, Biocon, Pfizer, Ono Pharmaceutical, GC Cell Corporation, Suzhou Zelgen Biopharmaceuticals, Aurigene Discovery Technologies Limited, Celltrion, Tianjin Hemay Pharmaceutical Co., Ltd, Innovent Biologics (Suzhou) Co. Ltd., Sinocelltech, Azora Therapeutics, and others.
• Plaque Psoriasis Pipeline Therapies- Tapinarof, Tapinarof cream 1%, Bimekizumab, Humira (Adalimumab), SB5 (Adalimumab Biosimilar), and others.
Dive deep into rich insights for new drugs for Plaque Psoriasis treatment, Visit @ Plaque Psoriasis Market Drivers and Barriers, and Future Perspective- https://www.delveinsight.com/sample-request/plaque-psoriasis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Table of Content
1. Introduction
2. Executive Summary
3. Plaque Psoriasis: Overview
4. Pipeline Therapeutics
5. Therapeutic Assessment
6. Plaque Psoriasis - DelveInsight's Analytical Perspective
7. Late Stage Products (Preregistration)
8. ARQ-151: Arcutis Biotherapeutics
9. Drug profiles in the detailed report…..
10. Mid Stage Products (Phase II)
11. ABY-035: Affibody
12. Drug profiles in the detailed report…..
13. Early Stage Products (Phase I)
14. CT303: GC Cell
15. Drug profiles in the detailed report…..
16. Preclinical and Discovery Stage Products
17. Drug name: Company name
18. Drug profiles in the detailed report…..
19. Inactive Products
20. Plaque Psoriasis Key Companies
21. Plaque Psoriasis Key Products
22. Plaque Psoriasis- Unmet Needs
23. Plaque Psoriasis- Market Drivers and Barriers
24. Plaque Psoriasis- Future Perspectives and Conclusion
25. Plaque Psoriasis Analyst Views
26. Plaque Psoriasis Key Companies
27. Appendix
For further information on the Plaque Psoriasis pipeline therapeutics, reach out to Plaque Psoriasis Unmet Needs and Analyst Views- https://www.delveinsight.com/sample-request/plaque-psoriasis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
List of Important Published Links
https://dennydones99.blogcudinti.com/profile
https://dennydones99.iyublog.com/profile
https://dennydones99.blogdiloz.com/profile
https://dennydones99.verybigblog.com/profile
https://dennydones99.activosblog.com/profile
https://dennydones99.p2blogs.com/profile
https://dennydones99.theblogfairy.com/profile
https://dennydones99.vidublog.com/profile
https://dennydones99.oblogation.com/profile
https://dennydones99.gynoblog.com/profile
https://dennydones99.laowaiblog.com/profile
https://dennydones99.angelinsblog.com/profile
https://dennydones99.humor-blog.com/profile
https://dennydones99.thekatyblog.com/profile
https://dennydones99.blogspothub.com/profile
https://dennydones99.idblogmaker.com/profile
https://dennydones99.blogdemls.com/profile
https://dennydones99.ageeksblog.com/profile
https://dennydones99.loginblogin.com/profile
https://dennydones99.mdkblog.com/profile
https://dennydones99.mybuzzblog.com/profile
https://dennydones99.newbigblog.com/profile
https://dennydones99.thenerdsblog.com/profile
https://dennydones99.theobloggers.com/profile
https://dennydones99.topbloghub.com/profile
https://dennydones99.ttblogs.com/profile
https://dennydones99.vblogetin.com/profile
https://dennydones99.win-blog.com/profile
https://dennydones99.bcbloggers.com/profile
https://dennydones99.shoutmyblog.com/profile
https://dennydones99.blogaritma.com/profile
https://dennydones99.rimmablog.com/profile
https://dennydones99.jts-blog.com/profile
https://dennydones99.blogsumer.com/profile
https://dennydones99.blognody.com/profile
https://dennydones99.yomoblog.com/profile
https://dennydones99.worldblogged.com/profile
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: ybhardwaj@delveinsight.com
Phone: 9193216187
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/consulting-services
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Plaque Psoriasis Pipeline Insights, FDA Approvals, Clinical Trials Assessment, and Companies 2024 here
News-ID: 3366739 • Views: …
More Releases from DelveInsight Business Research LLP
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight and stay ahead…
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore…
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight…
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market…
More Releases for Plaque
Best Plaque Removers: 2024 Ultimate Guide Released
With dental health becoming increasingly important to consumers, Verified Review Pro (https://www.verifiedreviewpro.com/best-plaque-tartar-removers/) has released their comprehensive analysis of the best plaque removers for 2024. This extensive guide arrives at a crucial time when more people are seeking effective home dental care solutions.
"The market for the best plaque removers has evolved significantly in recent years," explains Sarah Harrington, Lead Product Analyst at Verified Review Pro. "Our research shows that 78% of…
Denta Blast Ultrasonic Tooth Cleaner Reviews: Best Dentist plaque Remover
Denta Blast Ultrasonic Tooth Cleaner Reviews: Best Dentist plaque Remover
Oral health is very important for every individual and choosing the right way to go about it can determine how healthy your mouth would be. The mouth is filled with bacteria that need proper management to prevent oral health problems. It is important to take proper care of our mouth to prevent complications that result such as diabetes, heart disease, stroke…
SWISSKLIP PLAQUE BLASTER REVIEWS 2023:DON'T BE FOOLED!IS SWISSKLIP PLAQUE BLASTE …
Swissklip Plaque Blaster has been making waves in the dental hygiene market, gaining popularity and acclaim in the United States for its proven effectiveness in removing plaque. This innovative device has become a go-to solution for individuals seeking a reliable and efficient way to maintain optimal oral health. In this comprehensive Swissklip Plaque Blaster review, we will delve into the features, benefits, and overall worthiness of this product, giving you…
Plaque Psoriasis Market Report, History and Forecast 2023-2031
Plaque Psoriasis Market 2023 by Technology, Manufacturers, Regions, Type, and Application, Forecast guide to light the excellent analysis on the market synopsis. The report offers a primary focus on important factors in the global Plaque Psoriasis industry. The report includes perceptive information about gross revenue, cost, value, capacity, pricing, and profit margins concerning historical analysis and forecast estimation for the 2023 to 2031 time period. It presents a close overview…
Plaque Psoriasis Global Manufacturers Market by Valuates Reports
Latest Updates on Psoriasis market research
Psoriasis is a long-lasting autoimmune disease characterized by patches of abnormal skin. These skin patches are typically red, dry, itchy, and scaly.
Emerging Phase III products for Plaque Psoriasis
This report provides a comprehensive understanding of the emerging Phase III therapies for Plaque Psoriasis which can turn out to be future prospective competitors for the marketed products. It will also put light on the current…
Global Plaque Modification Devices Market Trend and Forecast 2025
This study focuses on the production side and consumption side of Plaque Modification Devices, presents the global Plaque Modification Devices market size by manufacturers, regions, type and application, history breakdown data from 2013 to 2018, and forecast to 2025.
In terms of production side, this report researches the Plaque Modification Devices capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and product type.
In terms of…
